12
All Exposed
In Utero
64
Marshallese.
(A)Tactudes some cases not surgically treated.
aAaNae MO
(C)gased on age lesa than ten prevalence.
~
(B)gaaed on prevalence in unexposed
~N
46
AN
251
7
16
2
All Ages
orer ar
—_
30
129
T<
2
Coa Gm
2)
-
oo
10-18
>18
.079(C)
Expected
Nod s}ea(8)
oo
oun
80
8
54
19
86
167
Ucirik
In Utero
<10
10-18
>18
Ail Ages
No. with
Carcinoma
Qam am NS
oS
~
CV]
2
-
2
15
3
3
23
Nodules (4)
2
-
<10
hl
19
1
1
3
19
vt
32
65
Total
Number
Sifo
In Utero
» <0
10-18
>18
All Ages
Ronge Lap
Ia Utero
<10
,
10-18
>18
All Ages
Age at
Exposure
600
4000
1700
1300
2100
610
1100
410
670
130
490
220
170
280
290
1400
760
470
790
0.0087(¢)
0.061
0.075
0.15
0.070)
0.47
0.24
0.59
1.4
0.10(C)
0.70
0.38
0.89
2.1
Mean
Adsorbed
Dose,
rade
0.026(C)
0.17
0.16
0.22
0.56
Cancers (©)
Expected
SUMMARY OF THYROID DATA
TABLE IV-17
ow
ADaon
oe
eooon +
‘
18(18)
2016)
20(22)
23(-)
16(18)
23(21)
22(-)
22(22)
~(-)
25(21)
-(-)
18(-)
19(-)
-(-)
22(-)
15(16)
23(-)
13415)
17(22)
4713)
(Cancer),
yeare
Mean Time
at Risk
Mean Nodule
Risk, no.
per 106 per
vad per year
Mean Cencer
Risk, no. per
106 per rad
per year